蓝舌病病毒内蒙古分离株VP2基因5''端序列分析及探针制备

从内蒙古巴盟地区分离的蓝舌病病毒株(BTV-NM)提取总RNA,经反转录PCR扩增VP2基因5′端片段,并构建至pGEM-T载体中.序列测定后,将这一序列与蓝舌病毒澳大利亚株VP2基因5′端进行比较分析:同源性为40%.通过PCR法标记克隆的cDNA片段,制备地高辛标记探针,与粗提的蓝舌病发病羊病毒RNA进行Northern blot杂交,并作敏感性试验,结果表明此探针对蓝舌病毒内蒙古分离株具有特异性,可检测出50 pg的病毒RNA.     

蓝舌病病毒内蒙古分离株VP_2基因5′端序列分析及探针制备

从内蒙古巴盟地区分离的蓝舌病病毒株(BTV-NM)提取总RNA,经反转录PCR扩增VP2基因5′端片段,并构建至pGEM-T载体中.序列测定后,将这一序列与蓝舌病毒澳大利亚株VP2基因5′端进行比较分析:同源性为40%.通过PCR法标记克隆的cDNA片段,制备地高辛标记探针,与粗提的蓝舌病发病羊病毒RNA进行Northernblot杂交,并作敏感性试验,结果表明此探针对蓝舌病毒内蒙古分离株具有特异性,可检测出50pg的病毒RNA.     

轮状病毒VP7基因的克隆及核苷酸序列分析

用反转录聚合酶链反应（RT－PCR）技术，从轮状病毒感染的细胞中扩增了916bp的VP7片段中抗原表位区。通过T4DNA连接酶将其直接连接于克隆载体质粒pGEM-T上，转化至受体菌DH5a中。提取质粒经PCR扩增、酶切鉴定，证明重组质粒pT-V7中含有轮状病毒的VP7基因片段。经核苷酸序列分析，表明正确克服了轮状病毒主要保护性抗VP7基因中抗原表位区。     

肠道病毒71型外壳蛋白VP3在Pichia.pastoris酵母中的表达

利用逆转录聚合酶链式反应(RT-PCR)的方法克隆肠道病毒71型SHZH98株外壳蛋白VP3基因,连接T载体,经序列测定后,构建酵母分泌型表达质粒pPIC9K/VP3,经序列测定证实-factor信号肽和VP3的序列和阅读框正确后,用SacI酶切使之线性化,电转化法将目的基因整合到宿主菌GS115基因组上;经转化子表型筛选和PCR分析鉴定后,甲醇诱导,筛选到5株高效表达VP3蛋白的工程菌株.ELISA实验表明:重组蛋白VP3具有较好的免疫原性.     

对虾白斑综合症病毒结构蛋白质VP41的研究

VP41蛋白质是对虾白斑综合症病毒的一种结构蛋白,该蛋白质由病毒基因组上的wsv242开放阅读框(ORF)所编码,分子量为41 ku.根据vp41基因的序列,通过PCR扩增获得了该全长基因,将其克隆在载体pET-His上,以E.coli BL21为宿主菌,成功表达并纯化了含His标记的目的蛋白VP41,并制备了特异性鼠抗血清.当纯化的病毒粒子经去污剂处理后,VP41蛋白质被发现完全存在于病毒WSSV囊膜部分,Western blot杂交实验也证实该结果,表明VP41蛋白质是该病毒的一个囊膜蛋白质.通过Far-Western方法还发现VP41具有蛋白聚合作用.     

蓝舌病病毒内蒙古分离株VP2基因5′端序列分析及探针制备

从内蒙古巴盟地区分离的蓝舌病病毒株(BTV—NM)提取总RNA，经反转录PCR扩增VP2基因5′端片段，并构建至pGEM—T载体中。序列测定后，将这一序列与蓝舌病毒澳大利亚株VP2基因5′端进行比较分析：同源性为40％。通过PCR法标记克隆的cDNA片段，制备地高辛标记探针，与粗提的蓝舌病发病羊病毒RNA进行Northernblot杂交，并作敏感性试验，结果表明此探针对蓝舌病毒内蒙古分离株具有特异性，可检测出50pg的病毒RNA。     

C6/36浓核病毒样颗粒在大肠杆菌中的表达与组装

通过PCR获得C6/36细胞浓核病毒(C6/36DNV)的结构蛋白VP1和VP2的基因,经克隆表达,在大肠杆菌中得到了含6×His标签的VP1或VP2的融合蛋白表达产物;两种表达产物经超速离心纯化后,在电镜下均观察到了大小(约25nm)和形态都与野生C6/36DNV相似的病毒样颗粒(VLPs),且两种VLPs(VP1-VLPs和VP2-VLPs)在电镜下未见有明显差别,说明VP1和VP2在大肠杆菌中表达后均可独立组装成VLPs.     

鹅细小病毒C日v强毒株VP3基因克隆及遗传进化

根据Genbank中的鹅细小病毒(GPV)B株全基因序列,设计合成一对引物,应用PCR技术扩增了GPV强毒株CHv的VP3基因片段,将扩增后的VP3基因重组到pMD18-T质粒载体上,并对擂人片段进行序列测定,将测序结果及由该结果推导的氨基酸序列与国内外分离的GPV,M DPV,PPV和CPV等不同宿主的细小病毒的VP3进行比对分析.结果表明:中国四川分离的GPV CHv株VP3基因长1 605 bp,编码 534个氨基酸,与国内外10株GPV的VP3基因进行比较,核苷酸同源性为93.4%-99.8%,氨基酸同源性为96.5%99.3%,其变异较小,是GPV保持一个血清型的分子基础.与番鸭细小病毒的核苷酸和氨基酸同源性分别为79.6%和89.9%,而与其他种属的细小病毒同源性均在30%以下,表明它们与GPV CHv株亲缘关系较远.     

猪脑心肌炎病毒VR-129 B株VP2重组蛋白的构建表达及其免疫活性分析

为获得大量猪脑心肌炎VP2基因及蛋白研究的细胞模型,构建pDC315-EMCV-VP2真核表达载体,且将其转染到293T细胞,筛选出阳性质粒进行克隆。EMCV VR-129B株VP2基因序列参照GenBank(登录号:X74312),利用RT—PCR方法扩增VP2的全基因序列,将其与质粒pDC315经NheI和XhoI双酶切后连接,构建pDC315-EMCV-VP2重组表达质粒,并将其转染至293T细胞。使用荧光定量PCR方法观察pDC315-EMCV-VP2真核表达载体在细胞中的表达情况。双酶切PCR结果获得大小为780 bp的基因片段,测序结果显示与GenBank上已经公布的同名基因(登录号:X74312)序列片段同源性为100%,重组质粒构建成功。实时荧光定量PCR(QPCR)结果显示,重组质粒转染组与空质粒组之间相比,EMCV-VP2基因的表达量显著上调(P0.001);在荧光显微镜下观察转染细胞,转染成功部分出现较亮绿色荧光,EMCV-VP2基因表达稳定。从转染细胞中提取重组蛋白与EMCV阳性血清和阴性血清进行ELisa反应,具有较好免疫活性。     

EGFR基因C端结构域真核表达载体的构建

构建EGFR基因C端结构域的真核表达载体.应用PCR技术,从含EGFR基因C端结构域的大肠杆菌DH 5α中扩增其序列,亚克隆到真核表达载体pcDNA3.1( )中,经酶切及测序进行验证.PCR扩增片段与预期结果相符,真核表达载体构建成功,测序结果与GenBank公布的基因一致.成功地构建了EGFR基因C端两个结构域的真核表达载体.     

Generation of VP5 deficient mutant of infectious bursal disease virus strain HZ2

Infectious bursal disease virus (IBDV) is one of the most significant viral pathogens in chickens[1]. It causes high mortality in young chickens and establishes an immunosuppression state by destroying the precursorsInfectious bursal disease virus (IBDV) …     

鸡传染性法氏囊病的RT-PCR诊断方法的研究

在研究鸡法氏囊病毒(IBDV)的A片断cDNA结构的基础上,建立了RT-PCR早期诊断技术.结果表明,使用PrimerDesign引物设计软件,在VP5和VP2的重叠基因区设计的一对引物具有非常高的同源性和保守性.采用的四种IBDV的标准毒株、一种野毒株和一例病鸡标本通过此引物进行RT-PCR检测均得到了明显的阳性扩增结果.而两种其他鸡病病毒和一例健康鸡的法氏囊组织扩增均为阴性结果.     

传染性法氏囊病病毒结构的分子生物学研究进展

传染性法氏囊病是一种严重危害雏鸡的免疫抑制性、高度接触性传染病.传染性法氏囊病病毒为双RNA病毒,有A、B两个片断.A片断编码4种蛋白VP2,VP3,VP4和VP5,B片断编码VP1蛋白.其中的VP2和VP3是主要的宿主保护性抗原,在病毒的结构、变异、毒力和免疫原性方面有着重要的作用.     

鸡传染性法氏囊病毒LS株的分离与鉴定

用SPF鸡胚,从江苏溧水某鸡场病死鸡的法氏囊组织中分离到一株病毒,接种健康非免疫鸡,能致鸡3～5 d内全部发病,死亡率达55%以上,腿肌和腺胃出血,肝和肾肿大出血,脾脏出血,法氏囊肿大出血;该病毒不能凝集鸡红细胞,可以与IBDV阳性血清产生沉淀;应用RT-PCR进行检测,扩增IBDV VP2基因,并与GenBank中的已知序列进行比较.结果表明,所分离的病毒为IBDV毒株.     

传染性法氏囊病病毒分子生物学研究的一些进展

对IBDV近年来的分子生物学方面的研究进展进行概况，主要包括IBDv的基因组结构及理化特性、病毒蛋白、不同型IBDV变异的分子基础和分子生物学诊断技术等，以探讨利用病毒重要基因核酸序列的差异进行IBDV分子流行病学研究及病毒各致病型快速鉴别诊断的可能性．     

Synthesis of brome mosaic virus subgenomic RNA in vitro by internal initiation on (-)-sense genomic RNA

The genomes of many (+)-stranded RNA viruses, including plant viruses and alphaviruses, consist of polycistronic RNAs whose internal genes are expressed via subgenomic messenger RNAs. The mechanism(s) by which these subgenomic mRNAs arise are poorly understood. Based on indirect evidence, three models have been proposed: (1) internal initiation by the replicase on the (-)-strand of genomic RNA, (2) premature termination during (-)-strand synthesis, followed by independent replication of the subgenomic RNA and (3) processing by nuclease cleavage of genome-length RNA. Using an RNA-dependent RNA polymerase (replicase) preparation from barley leaves infected with brome mosaic virus (BMV) to synthesize the viral subgenomic RNA in vitro, we now provide evidence that subgenomic RNA arises by internal initiation on the (-)-strand of genomic RNA. We believe that this also represents the first in vitro demonstration of a replicase from a eukaryotic (+)-stranded RNA virus capable of initiating synthesis of (+)-sense RNA.     

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

The innate immune system senses viral infection by recognizing a variety of viral components (including double-stranded (ds)RNA) and triggers antiviral responses. The cytoplasmic helicase proteins RIG-I (retinoic-acid-inducible protein I, also known as Ddx58) and MDA5 (melanoma-differentiation-associated gene 5, also known as Ifih1 or Helicard) have been implicated in viral dsRNA recognition. In vitro studies suggest that both RIG-I and MDA5 detect RNA viruses and polyinosine-polycytidylic acid (poly(I:C)), a synthetic dsRNA analogue. Although a critical role for RIG-I in the recognition of several RNA viruses has been clarified, the functional role of MDA5 and the relationship between these dsRNA detectors in vivo are yet to be determined. Here we use mice deficient in MDA5 (MDA5-/-) to show that MDA5 and RIG-I recognize different types of dsRNAs: MDA5 recognizes poly(I:C), and RIG-I detects in vitro transcribed dsRNAs. RNA viruses are also differentially recognized by RIG-I and MDA5. We find that RIG-I is essential for the production of interferons in response to RNA viruses including paramyxoviruses, influenza virus and Japanese encephalitis virus, whereas MDA5 is critical for picornavirus detection. Furthermore, RIG-I-/- and MDA5-/- mice are highly susceptible to infection with these respective RNA viruses compared to control mice. Together, our data show that RIG-I and MDA5 distinguish different RNA viruses and are critical for host antiviral responses.     

Location and primary structure of a major antigenic site for poliovirus neutralization

We have determined a major antigenic site for virus neutralization on the capsid protein VP1 of poliovirus type 3. Antigenic mutant viruses selected for resistance to individual monoclonal antibodies had point mutations concentrated in a region 277-294 bases downstream from the start of the region of viral RNA coding for VP1. These findings provide the basis for an improved understanding of the molecular basis of virus neutralization.     

鸡传染性法式囊病毒VP2原核表达蛋白的纯化和复性

对原核表达的鸡传染性法式囊病毒(IBDV)VP2蛋白进行可溶性分析与不可溶性分析,结果表明蛋白主要以包涵体形式存在,利用溶菌酶、Triton-100、尿素等试剂进行纯化和复性后,对复性前后的蛋白分别与特异性多抗进行Dot-ELISA,复性后蛋白的反应活性增强了10倍,对复性后的蛋白与IBDV16株单抗进行Dot-ELISA,其中有11株与其发生特异性反应.     

Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3

The three serotypes of poliovirus are members of the picornaviradae, a group of viruses which cause a variety of diseases of considerable importance in man and animals. We have previously used antigenic mutants resistant to neutralizing monoclonal antibodies to identify a single antigenic site for the neutralization of poliovirus type 3 (ref. 1). Evidence based on oligonucleotide mapping suggested that this site corresponded largely to one physicochemical region of the capsid protein viral polypeptide 1 (VP1). We now present conclusive evidence that most of the mutations conferring resistance to neutralization are confined to an eight-amino acid region of VP1, specified by a sequence of viral RNA 277-300 bases from the start of the region coding for VP1. These data strongly suggest that this small region constitutes a major antigenic site involved in virus neutralization and they provide the most detailed information currently available on the antigenic site of a human virus.